Your browser doesn't support javascript.
loading
Translational study identifies XPF and MUS81 as predictive biomarkers for oxaliplatin-based peri-operative chemotherapy in patients with esophageal adenocarcinoma.
MacGregor, T P; Carter, R; Gillies, R S; Findlay, J M; Kartsonaki, C; Castro-Giner, F; Sahgal, N; Wang, L M; Chetty, R; Maynard, N D; Cazier, J B; Buffa, F; McHugh, P J; Tomlinson, I; Middleton, M R; Sharma, R A.
Afiliación
  • MacGregor TP; NIHR Oxford Biomedical Research Centre, Department of Oncology, University of Oxford, Oxford, UK.
  • Carter R; NIHR Oxford Biomedical Research Centre, Department of Oncology, University of Oxford, Oxford, UK.
  • Gillies RS; NIHR Oxford Biomedical Research Centre, Department of Oncology, University of Oxford, Oxford, UK.
  • Findlay JM; Department of Upper GI Surgery, Churchill Hospital, Oxford, UK.
  • Kartsonaki C; Department of Upper GI Surgery, Churchill Hospital, Oxford, UK.
  • Castro-Giner F; Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford, UK.
  • Sahgal N; NIHR Oxford Biomedical Research Centre, Department of Oncology, University of Oxford, Oxford, UK.
  • Wang LM; Nuffield Department of Population Health, University of Oxford, Oxford, UK.
  • Chetty R; Medical Research Council Population Health Research Unit (MRC PHRU) at the University of Oxford, Oxford, UK.
  • Maynard ND; Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford, UK.
  • Cazier JB; Ludwig Institute for Cancer Research, University of Oxford, Nuffield Department of Medicine, Oxford, UK.
  • Buffa F; NIHR Oxford Biomedical Research Centre/Department of Cellular Pathology/Radcliffe Department of Medicine, Oxford University Hospitals and University of Oxford, Oxford, UK.
  • McHugh PJ; Department of Laboratory Medicine, Changi General Hospital, Singapore, Singapore.
  • Tomlinson I; Laboratory Medicine Programme, University Health Network, Toronto, Canada.
  • Middleton MR; Department of Upper GI Surgery, Churchill Hospital, Oxford, UK.
  • Sharma RA; NIHR Oxford Biomedical Research Centre, Department of Oncology, University of Oxford, Oxford, UK.
Sci Rep ; 8(1): 7265, 2018 05 08.
Article en En | MEDLINE | ID: mdl-29739952
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Esofágicas / Adenocarcinoma / Proteínas de Unión al ADN / Endonucleasas Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Sci Rep Año: 2018 Tipo del documento: Article País de afiliación: Reino Unido Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Esofágicas / Adenocarcinoma / Proteínas de Unión al ADN / Endonucleasas Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Sci Rep Año: 2018 Tipo del documento: Article País de afiliación: Reino Unido Pais de publicación: Reino Unido